CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 500 shares, an increase of 25.0% from the September 30th total of 400 shares. Based on an average trading volume of 38,300 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Macquarie upgraded CSL to a “strong-buy” rating in a research note on Tuesday, August 13th.

CSL Trading Down 1.0 %

Shares of CSLLY stock traded down $0.94 during trading hours on Tuesday, reaching $96.41. The company’s stock had a trading volume of 22,911 shares, compared to its average volume of 29,269. The firm’s 50 day simple moving average is $100.85 and its 200-day simple moving average is $97.91. CSL has a fifty-two week low of $71.51 and a fifty-two week high of $109.00. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.